Responses and durability of clinical benefit in non-small cell lung cancer treated with pegilodecakin in combination with anti-PD-1 inhibitors Meeting Abstract
| Authors: | Garon, E. B.; Wong, D. J.; Schneider, J. G.; Aljumaily, R.; Korn, W. M.; Patel, M. R.; Autio, K. A.; Papadopoulos, K. P.; Naing, A.; Gabrail, N.; Munster, P. N.; Goldman, J.; Hung, A.; Oft, M.; Leveque, J.; Spigel, D. R. |
| Abstract Title: | Responses and durability of clinical benefit in non-small cell lung cancer treated with pegilodecakin in combination with anti-PD-1 inhibitors |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy288.017 |
| Language: | English |
| ACCESSION: | WOS:000459277302323 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy288.017 |
| Notes: | Meeting Abstract: 1144P -- Appears on page viii407 of the abstract book -- Source: Wos |
